Original Research
Published on 12 Feb 2021
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2020.619469
- 7,001 views
- 17 citations
